Literature DB >> 24661468

Psychogenic axial myoclonus: clinical features and long-term outcome.

Roberto Erro1, Mark J Edwards2, Kailash P Bhatia2, Marcello Esposito3, Simon F Farmer4, Carla Cordivari5.   

Abstract

BACKGROUND: It has been increasingly recognized that the majority of patients with a diagnosis of idiopathic propriospinal myoclonus have either a subsequent clinical course or electrophysiological features indicating that the likely etiology is psychogenic. However, the clinical features of psychogenic axial myoclonus and the long-term outcome have not yet well characterized. PATIENTS AND METHODS: Here we describe clinical findings with representative videos and long term outcomes of 76 patients with an electrophysiologically established diagnosis of psychogenic axial myoclonus.
RESULTS: Thirty-seven patients were male. Mean age at onset of symptoms was 40.1 ± 15.1 years. Thirty-two patients (42.1%) presented with isolated axial myoclonus, while 44 patients (57.9%) presented additional features, including involvement of face or limb. In all patients but six (7.9%), the axial myoclonus was in flexion. In more than one-third of patients (42.1%), jerks were multifocal, meaning that there was no clear stereotyped pattern of jerks. Comparison between groups stratified according to the clinical outcome, revealed "delay of diagnosis" as the only predictor of worse outcome. DISCUSSION: We describe here the clinical features and long-term outcome on the largest series of patients with psychogenic axial myoclonus reported in the literature. The description of our series highlights a number of clinical features, which may help neurologists to reach a correct diagnosis on clinical grounds alone. Delay in diagnosis of a psychogenic disorder has a negative effect on long-term outcome.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Axial jerks; Bereitschafts potential; Functional movement disorders; PSM; Propriospinal myoclonus; Psychogenic movement disorders

Mesh:

Year:  2014        PMID: 24661468     DOI: 10.1016/j.parkreldis.2014.02.026

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  6 in total

Review 1.  Psychogenic nonepileptic seizures and movement disorders: A comparative review.

Authors:  Roberto Erro; Francesco Brigo; Eugen Trinka; Giulia Turri; Mark J Edwards; Michele Tinazzi
Journal:  Neurol Clin Pract       Date:  2016-04

2.  A restless abdomen and propriospinal myoclonus like at sleep onset: an unusual overlap syndrome.

Authors:  Simone Baiardi; Chiara La Morgia; Susanna Mondini; Fabio Cirignotta
Journal:  BMJ Case Rep       Date:  2015-03-27

Review 3.  Myoclonus: An Electrophysiological Diagnosis.

Authors:  Shabbir Hussain I Merchant; Felipe Vial-Undurraga; Giorgio Leodori; Jay A van Gerpen; Mark Hallett
Journal:  Mov Disord Clin Pract       Date:  2020-06-17

Review 4.  Spinal-generated movement disorders: a clinical review.

Authors:  Pichet Termsarasab; Thananan Thammongkolchai; Steven J Frucht
Journal:  J Clin Mov Disord       Date:  2015-12-24

5.  Botulinum neurotoxin treatment in jerky and tremulous functional movement disorders: a double-blind, randomised placebo-controlled trial with an open-label extension.

Authors:  Yasmine Emma Maria Dreissen; Joke M Dijk; Jeannette M Gelauff; Evelien Zoons; Daniël van Poppelen; Maria Fiorella Contarino; Rodi Zutt; Bart Post; Alexander G Munts; Johannes D Speelman; Danielle C Cath; Rob J de Haan; Johannes Htm Koelman; Marina A J Tijssen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2019-06-20       Impact factor: 10.154

Review 6.  Current Concepts in Diagnosis and Treatment of Functional Neurological Disorders.

Authors:  Alberto J Espay; Selma Aybek; Alan Carson; Mark J Edwards; Laura H Goldstein; Mark Hallett; Kathrin LaFaver; W Curt LaFrance; Anthony E Lang; Tim Nicholson; Glenn Nielsen; Markus Reuber; Valerie Voon; Jon Stone; Francesca Morgante
Journal:  JAMA Neurol       Date:  2018-09-01       Impact factor: 18.302

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.